Iloprost, a prostacyclin analog, inhibits the invasion of ovarian cancer cells by downregulating matrix metallopeptidase-2 (MMP-2) through the IP-dependent pathway-Reference-Cited by-同舟云学术

Iloprost, a prostacyclin analog, inhibits the invasion of ovarian cancer cells by downregulating matrix metallopeptidase-2 (MMP-2) through the IP-dependent pathway

Published:2018-01 Issue: Volume:134 Page:47-56
ISSN:1098-8823
Container-title:Prostaglandins & Other Lipid Mediators
language:en
Short-container-title:Prostaglandins & Other Lipid Mediators

Author:

Ahn Ji-Hye,Lee Kyung-Tae,Choi Youn Seok,Choi Jung-Hye

Funder

Ministry of Science and ICT

Publisher

Elsevier BV

Subject

Cell Biology,Pharmacology,Physiology,Biochemistry

Reference54 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J. Clin.,2016

2. Novel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancer;Ren;Biochim. Biophys. Acta,2016

3. Prostacyclin and its analogues: antimetastatic effects and mechanisms of action;Schneider;Cancer Metastasis Rev.,1994

4. The acute effect of the synthetic prostacyclin analogue iloprost in primary pulmonary hypertension;Scott;Br. J. Clin. Pract.,1990

5. Inhaled iloprost reverses vascular remodeling in chronic experimental pulmonary hypertension;Schermuly;Am. J. Respir. Crit. Care Med.,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scientific and clinical relevance of non-cellular tumor microenvironment components in ovarian cancer chemotherapy resistance;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-01

2. Fatty acids in cancer: Metabolic functions and potential treatment;MedComm – Oncology;2023-03

3. Prostacyclin Released by Cancer-Associated Fibroblasts Promotes Immunosuppressive and Pro-Metastatic Macrophage Polarization in the Ovarian Cancer Microenvironment;Cancers;2022-12-13

4. Prostanoid Signaling in Cancers: Expression and Regulation Patterns of Enzymes and Receptors;Biology;2022-04-13

5. Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy;Cancer Research;2021-12-23